<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">scbmt</journal-id><journal-title-group><journal-title xml:lang="ru">БИОМЕДИЦИНА</journal-title><trans-title-group xml:lang="en"><trans-title>Journal Biomed</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2074-5982</issn><issn pub-type="epub">2713-0428</issn><publisher><publisher-name>Scientific center of biomedical technologies of Federal Medical and Biological Agency</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.33647/2713-0428-17-3E-161-164</article-id><article-id custom-type="elpub" pub-id-type="custom">scbmt-1334</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ДОКЛИНИЧЕСКИЕ ИССЛЕДОВАНИЯ В БИОМЕДИЦИНЕ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>NON-CLINICAL RESEARCH IN BIOMEDICINE</subject></subj-group></article-categories><title-group><article-title>Седативная активность нового производного аллилморфолина у Danio rerio в тесте «Новый аквариум»</article-title><trans-title-group xml:lang="en"><trans-title>Edative activity of a new allylmorpholine derivative in the novel tank diving test in zebrafish Danio rerio</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Приходько</surname><given-names>В. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Prikhodko</surname><given-names>V. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>197376, Санкт-Петербург, ул. Профессора Попова, 14, лит. А</p></bio><bio xml:lang="en"><p>197376, St. Petersburg, Professora Popova Str., 14, let. A</p></bio><email xlink:type="simple">veronika.prihodko@pharminnotech.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Сысоев</surname><given-names>Ю. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Sysoev</surname><given-names>Yu. I.</given-names></name></name-alternatives><bio xml:lang="ru"><p>к.б.н., 197376, Санкт-Петербург, ул. Профессора Попова, 14, лит. А;</p><p>199034, Санкт-Петербург, Университетская наб., 7–9</p></bio><bio xml:lang="en"><p>Cand. Sci. (Biol.), 197376, St. Petersburg, Professora Popova Str., 14, let. A;</p><p>199034, St. Petersburg, Universitetskaya Embankment, 7–9</p></bio><email xlink:type="simple">susoev92@mail.ru</email><xref ref-type="aff" rid="aff-2"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru">ФГБОУ ВО «Санкт-Петербургский государственный химико-фармацевтический университет»&#13;
Минздрава России<country>Россия</country></aff><aff xml:lang="en">St. Petersburg State Chemical and Pharmaceutical University of the Ministry of Health Сare of Russia<country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru">ФГБОУ ВО «Санкт-Петербургский государственный химико-фармацевтический университет»&#13;
Минздрава России;&#13;
ФГБОУ ВО «Санкт-Петербургский государственный университет»<country>Россия</country></aff><aff xml:lang="en">St. Petersburg State Chemical and Pharmaceutical University of the Ministry of Health Сare of Russia;&#13;
St. Petersburg State University<country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2021</year></pub-date><pub-date pub-type="epub"><day>26</day><month>10</month><year>2021</year></pub-date><volume>17</volume><issue>3E</issue><fpage>161</fpage><lpage>164</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Приходько В.А., Сысоев Ю.И., 2021</copyright-statement><copyright-year>2021</copyright-year><copyright-holder xml:lang="ru">Приходько В.А., Сысоев Ю.И.</copyright-holder><copyright-holder xml:lang="en">Prikhodko V.A., Sysoev Y.I.</copyright-holder><license license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://journal.scbmt.ru/jour/article/view/1334">https://journal.scbmt.ru/jour/article/view/1334</self-uri><abstract><p>Проведена оценка влияния нового хромонсодержащего производного аллилморфолина (E)-4-[1-(8- бром-6-метил-4-оксо-4Н-хромен-3-ил)-4-метилпент-1-ен-3-ил]морфолин-4-ия хлорида на поведение рыб Danio rerio в тесте «Новый аквариум». На основании наблюдаемых изменений в поведении рыб установлено наличие у исследуемого соединения седативной активности. </p></abstract><trans-abstract xml:lang="en"><p>A new chromone-containing allylmorpholine derivative, (E)-4-[1-(8-bromo-6-methyl-4-oxo-4H-chromen3-yl)-4-methylpent-1-en-3-yl]morpholin-4-ium chloride, was screened for behavioral effects in zebrafish Danio rerio using the novel tank diving test. Based on the observed alterations in behavior, the compound was confirmed to exert a sedative effect in zebrafish. </p></trans-abstract><kwd-group xml:lang="ru"><kwd>производные аллилморфолина</kwd><kwd>Danio rerio</kwd><kwd>поведенческие тесты</kwd><kwd>новый аквариум</kwd><kwd>седативные средства</kwd></kwd-group><kwd-group xml:lang="en"><kwd>allylmorpholines</kwd><kwd>zebrafish</kwd><kwd>Danio rerio</kwd><kwd>behavioral testing</kwd><kwd>novel tank test</kwd><kwd>sedatives</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Chernov N.M., Shutov R.V., Barygin O.I., et al. Synthesis of chromone-containing allylmorpholines through a Morita-Baylis-Hillman-type reaction. Eur. J. Org. Chem. 2018;2018(45):6304–6313. DOI: 10.1002/ejoc.201801159.</mixed-citation><mixed-citation xml:lang="en">Chernov N.M., Shutov R.V., Barygin O.I., et al. Synthesis of chromone-containing allylmorpholines through a Morita-Baylis-Hillman-type reaction. Eur. J. Org. Chem. 2018;2018(45):6304–6313. DOI: 10.1002/ejoc.201801159.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Demin K.A., Kolesnikova T.O., Khatsko S.L., et al. Acute effects of amitriptyline on adult zebrafish: Potential relevance to antidepressant drug screening and modeling human toxidromes. Neurotoxicol. Teratol. 2017;62:27–33. DOI: 10.1016/j.ntt.2017.04.002.</mixed-citation><mixed-citation xml:lang="en">Demin K.A., Kolesnikova T.O., Khatsko S.L., et al. Acute effects of amitriptyline on adult zebrafish: Potential relevance to antidepressant drug screening and modeling human toxidromes. Neurotoxicol. Teratol. 2017;62:27–33. DOI: 10.1016/j.ntt.2017.04.002.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Egan R.J., Bergner C.L., Hart P.C., et al. Understanding behavioral and physiological phenotypes of stress and anxiety in zebrafish. Behav. Brain Res. 2009;205(1):38–44. DOI: 10.1016/j.bbr.2009.06.022.</mixed-citation><mixed-citation xml:lang="en">Egan R.J., Bergner C.L., Hart P.C., et al. Understanding behavioral and physiological phenotypes of stress and anxiety in zebrafish. Behav. Brain Res. 2009;205(1):38–44. DOI: 10.1016/j.bbr.2009.06.022.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
